Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DAWN – Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc
DAWN
$6.33
Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $641,621,440.00
EPSttm : -0.65
finviz dynamic chart for DAWN
Day One Biopharmaceuticals, Inc
$6.33
3.80%
$0.25

Float Short %

23.83

Margin Of Safety %

Put/Call OI Ratio

0.3

EPS Next Q Diff

0.03

EPS Last/This Y

-0.32

EPS This/Next Y

0.53

Price

6.33

Target Price

28

Analyst Recom

1.22

Performance Q

-46.9

Relative Volume

1.5

Beta

-1.28

Ticker: DAWN




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14DAWN7.210.451.257007
2025-04-15DAWN7.20.460.557025
2025-04-16DAWN6.760.44999.997149
2025-04-17DAWN6.840.360.006734
2025-04-18DAWN6.840.360.006734
2025-04-21DAWN7.140.460.004611
2025-04-22DAWN7.350.460.034611
2025-04-23DAWN7.430.451.504660
2025-04-24DAWN7.890.460.114684
2025-04-25DAWN7.740.456920684292380.105263157894744684
2025-04-28DAWN7.740.456920684292380.105263157894744684
2025-04-29DAWN7.670.460.114684
2025-04-30DAWN7.760.460.164695
2025-05-01DAWN7.60.450.004759
2025-05-02DAWN7.920.450.004757
2025-05-05DAWN7.480.420.005021
2025-05-06DAWN6.970.410.025081
2025-05-07DAWN6.30.410.105102
2025-05-08DAWN6.740.420.175084
2025-05-09DAWN6.450.41999.995155
2025-05-12DAWN6.580.410.005155
2025-05-13DAWN6.340.300.024796
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14DAWN7.2240.4- -1.42
2025-04-15DAWN7.1940.4- -1.42
2025-04-16DAWN6.7740.4- -1.42
2025-04-17DAWN6.8440.4- -1.42
2025-04-18DAWN6.8440.4- -1.42
2025-04-21DAWN7.1440.4- -1.55
2025-04-22DAWN7.3340.4- -1.55
2025-04-23DAWN7.4440.0- -1.59
2025-04-24DAWN7.8840.0- -1.59
2025-04-25DAWN7.7440.0- -1.59
2025-04-28DAWN7.7440.0- -1.59
2025-04-29DAWN7.6840.0- -1.59
2025-04-30DAWN7.7640.0- -1.59
2025-05-01DAWN7.6039.0- -1.61
2025-05-02DAWN7.9339.0- -1.61
2025-05-05DAWN7.4739.0- -1.61
2025-05-06DAWN6.9739.0- -1.61
2025-05-07DAWN6.3039.0- -1.61
2025-05-08DAWN6.74-630.7- -1.50
2025-05-09DAWN6.45-630.7- -1.34
2025-05-12DAWN6.58-630.7- -1.34
2025-05-13DAWN6.33-583.4- -1.34
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14DAWN-0.402.0923.53
2025-04-15DAWN-0.402.0923.53
2025-04-16DAWN-0.402.0923.53
2025-04-17DAWN-0.402.0923.53
2025-04-18DAWN-0.402.0923.53
2025-04-21DAWN-0.401.8923.53
2025-04-22DAWN-0.401.8923.53
2025-04-23DAWN-0.401.8923.53
2025-04-24DAWN-0.401.8923.53
2025-04-25DAWN-0.401.8923.53
2025-04-28DAWN-0.401.9024.51
2025-04-29DAWN-0.401.9024.51
2025-04-30DAWN-0.401.9024.51
2025-05-01DAWN-0.401.9024.51
2025-05-02DAWN-0.401.9024.51
2025-05-05DAWN-0.40-0.3324.51
2025-05-06DAWN-0.40-0.3324.51
2025-05-07DAWN-0.40-0.3324.51
2025-05-08DAWN-0.40-0.3324.51
2025-05-09DAWN-0.36-0.3324.51
2025-05-12DAWN-0.360.0523.83
2025-05-13DAWN-0.260.0523.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.35

Avg. EPS Est. Current Quarter

-0.34

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

-0.26

Institutional Transactions

0.05

Beta

-1.28

Average Sales Estimate Current Quarter

35

Average Sales Estimate Next Quarter

39

Fair Value

Quality Score

46

Growth Score

26

Sentiment Score

1

Actual DrawDown %

77.9

Max Drawdown 5-Year %

Target Price

28

P/E

Forward P/E

PEG

P/S

3.96

P/B

1.34

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y​

-1.34

EPS Next Y. (Est.)

-0.81

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-42.66

Relative Volume

1.5

Return on Equity vs Sector %

-38.1

Return on Equity vs Industry %

-21.1

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.08

EBIT Estimation

Day One Biopharmaceuticals, Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading